SIMILAR PATTERNS OF AMINO ACIDS FOR 4YPA_A_SAMA3004
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1hdi | PHOSPHOGLYCERATEKINASE (Sus scrofa) |
PF00162(PGK) | 5 | GLY A 365HIS A 390TYR A 195GLN A 332ILE A 369 | None | 1.31A | 4ypaA-1hdiA:undetectable | 4ypaA-1hdiA:20.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mvh | CRYPTIC LOCIREGULATOR 4 (Schizosaccharomycespombe) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 339TRP A 340TYR A 381ASN A 409HIS A 410 | None | 0.40A | 4ypaA-1mvhA:16.2 | 4ypaA-1mvhA:29.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mvh | CRYPTIC LOCIREGULATOR 4 (Schizosaccharomycespombe) |
PF00856(SET)PF05033(Pre-SET) | 5 | LYS A 338GLY A 339TYR A 381ASN A 409HIS A 410 | None | 1.12A | 4ypaA-1mvhA:16.2 | 4ypaA-1mvhA:29.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A 160TRP A 161ASN A 241HIS A 242TYR A 283CYH A 308 | SAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 (-2.2A) | 1.20A | 4ypaA-1pegA:18.6 | 4ypaA-1pegA:29.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 8 | GLY A 160TRP A 161ASP A 202TYR A 204ASN A 241HIS A 242TYR A 283CYH A 306 | SAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-3.6A)SAH A 319 (-4.0A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 ( 2.3A) | 0.71A | 4ypaA-1pegA:18.6 | 4ypaA-1pegA:29.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 151TRP A 152HIS A 220TYR A 261CYH A 289 | SAM A 304 (-3.5A)NoneSAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) | 1.31A | 4ypaA-2r3aA:19.2 | 4ypaA-2r3aA:28.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 8 | GLY A 151TRP A 152TYR A 193ASN A 219HIS A 220TYR A 261CYH A 287LYS A 288 | SAM A 304 (-3.5A)NoneSAM A 304 (-4.2A)SAM A 304 (-3.3A)SAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A)None | 0.69A | 4ypaA-2r3aA:19.2 | 4ypaA-2r3aA:28.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 153TYR A 193HIS A 220TYR A 261CYH A 287 | NoneSAM A 304 (-4.2A)SAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) | 1.46A | 4ypaA-2r3aA:19.2 | 4ypaA-2r3aA:28.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | GLY A3840ASN A3906HIS A3907TYR A3944CYH A3957 | SAH A4971 ( 3.7A)SAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A) ZN A4970 ( 2.3A) | 0.28A | 4ypaA-2w5zA:14.6 | 4ypaA-2w5zA:27.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | GLY A3840ASN A3906HIS A3907TYR A3944CYH A3959 | SAH A4971 ( 3.7A)SAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A) ZN A4970 (-2.3A) | 1.18A | 4ypaA-2w5zA:14.6 | 4ypaA-2w5zA:27.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | GLY A3840TYR A3883ASN A3906HIS A3907TYR A3944 | SAH A4971 ( 3.7A)NoneSAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A) | 0.66A | 4ypaA-2w5zA:14.6 | 4ypaA-2w5zA:27.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 138TYR A 178HIS A 210TYR A 248CYH A 273 | NoneSAH A 305 (-4.0A)NoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 1.31A | 4ypaA-3bo5A:20.6 | 4ypaA-3bo5A:28.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | LYS A 135GLY A 136TRP A 137HIS A 210TYR A 248CYH A 275 | NoneSAH A 305 (-3.8A)NoneNoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 1.48A | 4ypaA-3bo5A:20.6 | 4ypaA-3bo5A:28.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 8 | LYS A 135GLY A 136TRP A 137TYR A 178ASN A 209HIS A 210TYR A 248CYH A 273 | NoneSAH A 305 (-3.8A)NoneSAH A 305 (-4.0A)SAH A 305 (-3.4A)NoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 0.24A | 4ypaA-3bo5A:20.6 | 4ypaA-3bo5A:28.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | LYS A 17GLY A 16HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.31A | 4ypaA-3n71A:6.0 | 4ypaA-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 6 | LYS A 17GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.85A | 4ypaA-3n71A:6.0 | 4ypaA-3n71A:18.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 6 | GLY A 102TRP A 103ASN A 169HIS A 170TYR A 207CYH A 221 | SAM A 237 ( 3.7A)NoneSAM A 237 (-3.3A)SAM A 237 (-4.7A)None ZN A 232 (-2.3A) | 1.14A | 4ypaA-3ooiA:27.0 | 4ypaA-3ooiA:41.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 7 | GLY A 102TRP A 103TYR A 146ASN A 169HIS A 170TYR A 207CYH A 219 | SAM A 237 ( 3.7A)NoneSAM A 237 (-4.1A)SAM A 237 (-3.3A)SAM A 237 (-4.7A)None ZN A 232 ( 2.3A) | 0.28A | 4ypaA-3ooiA:27.0 | 4ypaA-3ooiA:41.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 6 | TYR A 146ASN A 169HIS A 170TYR A 207CYH A 219LYS A 220 | SAM A 237 (-4.1A)SAM A 237 (-3.3A)SAM A 237 (-4.7A)None ZN A 232 ( 2.3A)None | 0.54A | 4ypaA-3ooiA:27.0 | 4ypaA-3ooiA:41.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 5 | GLY A2153TYR A2194HIS A2218TYR A2255CYH A2268 | NoneSAM A 7 (-3.4A)NoneNone ZN A 1 ( 2.5A) | 1.42A | 4ypaA-3opeA:33.3 | 4ypaA-3opeA:97.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 7 | LYS A2150GLY A2151TRP A2152ASN A2217HIS A2218TYR A2255CYH A2270 | NoneSAM A 7 (-3.4A)NoneSAM A 7 (-3.9A)NoneNone ZN A 1 (-2.7A) | 1.30A | 4ypaA-3opeA:33.3 | 4ypaA-3opeA:97.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 12 | LYS A2150GLY A2151TRP A2152ASP A2192TYR A2194ASN A2217HIS A2218TYR A2255GLN A2266CYH A2268LYS A2269ILE A2279 | NoneSAM A 7 (-3.4A)NoneSAM A 7 (-3.9A)SAM A 7 (-3.4A)SAM A 7 (-3.9A)NoneNoneSAM A 7 (-2.9A) ZN A 1 ( 2.5A)NoneNone | 0.52A | 4ypaA-3opeA:33.3 | 4ypaA-3opeA:97.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rc0 | N-LYSINEMETHYLTRANSFERASESETD6 (Homo sapiens) |
PF00856(SET)PF09273(Rubis-subs-bind) | 5 | GLY A 74TYR A 223ASN A 251HIS A 252TYR A 285 | SAM A 484 (-3.4A)SAM A 484 (-3.6A)SAM A 484 (-3.1A)NoneSAM A 484 (-4.8A) | 0.86A | 4ypaA-3rc0A:6.2 | 4ypaA-3rc0A:19.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 8 | LYS A1560GLY A1561TRP A1562TYR A1605ASN A1628HIS A1629GLN A1676CYH A1678 | None0UM A1804 (-3.5A)None0UM A1804 (-4.2A)0UM A1804 (-3.3A)None0UM A1804 (-3.3A) ZN A1803 ( 2.2A) | 0.40A | 4ypaA-4fmuA:25.8 | 4ypaA-4fmuA:37.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mi5 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A 628TRP A 629ASN A 693HIS A 694TYR A 731 | None | 0.66A | 4ypaA-4mi5A:15.2 | 4ypaA-4mi5A:30.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 7 | LYS A 456GLY A 457TRP A 458ASN A 551HIS A 552TYR A 593CYH A 612 | SAH A 801 (-4.7A)SAH A 801 (-3.6A)SAH A 801 (-4.9A)SAH A 801 (-3.2A)NoneNone ZN A 805 ( 2.4A) | 0.42A | 4ypaA-4qeoA:17.4 | 4ypaA-4qeoA:19.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 7 | LYS A 456GLY A 457TYR A 493ASN A 551HIS A 552TYR A 593CYH A 612 | SAH A 801 (-4.7A)SAH A 801 (-3.6A)SAH A 801 (-4.0A)SAH A 801 (-3.2A)NoneNone ZN A 805 ( 2.4A) | 0.38A | 4ypaA-4qeoA:17.4 | 4ypaA-4qeoA:19.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4w2r | ENHANCER OF ZESTE 2POLYCOMB REPRESSIVECOMPLEX 2 SUBUNIT (Anoliscarolinensis) |
no annotation | 5 | GLY A 520TRP A 521ASN A 585HIS A 586TYR A 623 | CJD A 708 (-3.6A)NoneCJD A 708 (-3.5A)NoneNone | 0.52A | 4ypaA-4w2rA:21.6 | 4ypaA-4w2rA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z4p | HISTONE-LYSINEN-METHYLTRANSFERASE2D (Homo sapiens) |
PF00856(SET) | 5 | GLY A5408ASN A5474HIS A5475TYR A5512CYH A5527 | SAH A5602 (-3.6A)SAH A5602 (-3.1A)NoneNone ZN A5601 ( 2.2A) | 1.08A | 4ypaA-4z4pA:16.6 | 4ypaA-4z4pA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z4p | HISTONE-LYSINEN-METHYLTRANSFERASE2D (Homo sapiens) |
PF00856(SET) | 6 | GLY A5408TYR A5451ASN A5474HIS A5475TYR A5512CYH A5525 | SAH A5602 (-3.6A)SAH A5602 (-4.5A)SAH A5602 (-3.1A)NoneNone ZN A5601 ( 2.2A) | 0.45A | 4ypaA-4z4pA:16.6 | 4ypaA-4z4pA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f59 | HISTONE-LYSINEN-METHYLTRANSFERASE2C (Homo sapiens) |
PF00856(SET) | 6 | GLY A4782TYR A4825ASN A4848HIS A4849TYR A4886CYH A4899 | SAH A5002 (-3.5A)SAH A5002 (-4.5A)SAH A5002 (-2.7A)SAH A5002 (-4.6A)None ZN A5001 ( 2.0A) | 0.66A | 4ypaA-5f59A:16.1 | 4ypaA-5f59A:24.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 6 | GLY A3840TYR A3883ASN A3906HIS A3907TYR A3944CYH A3957 | SAH A4001 (-3.4A)NoneSAH A4001 (-3.0A)SAH A4001 (-4.9A)SAH A4001 (-4.9A) ZN A4002 ( 2.3A) | 0.58A | 4ypaA-5f6lA:16.3 | 4ypaA-5f6lA:24.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homo sapiens) |
PF00856(SET)PF01753(zf-MYND) | 6 | LYS A 17GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.03A | 4ypaA-5kjmA:6.3 | 4ypaA-5kjmA:20.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ls6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET)PF11616(EZH2_WD-Binding) | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | 74D A 809 ( 3.9A)None74D A 809 (-3.0A)NoneNone | 0.72A | 4ypaA-5ls6A:18.7 | 4ypaA-5ls6A:14.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 7 | GLY A1074TRP A1075TYR A1118ASN A1141HIS A1142TYR A1179CYH A1191 | SAM A1304 ( 3.2A)NoneSAM A1304 (-3.8A)SAM A1304 (-2.9A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 ( 2.3A) | 0.26A | 4ypaA-5lsuA:27.7 | 4ypaA-5lsuA:36.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 6 | GLY A1074TRP A1075TYR A1118HIS A1142TYR A1179CYH A1193 | SAM A1304 ( 3.2A)NoneSAM A1304 (-3.8A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 (-2.3A) | 1.35A | 4ypaA-5lsuA:27.7 | 4ypaA-5lsuA:36.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A1076TYR A1118HIS A1142TYR A1179CYH A1193 | SAM A1304 ( 4.6A)SAM A1304 (-3.8A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 (-2.3A) | 1.01A | 4ypaA-5lsuA:27.7 | 4ypaA-5lsuA:36.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mi0 | RETICULOCYTEBINDING-LIKE PROTEIN5,RETICULOCYTEBINDING PROTEIN 5 (Plasmodiumfalciparum) |
no annotation | 5 | GLY A 355ASN A 191HIS A 187TYR A 466ILE A 364 | None | 1.47A | 4ypaA-5mi0A:undetectable | 4ypaA-5mi0A:20.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5teg | N-LYSINEMETHYLTRANSFERASEKMT5A (Homo sapiens) |
PF00856(SET) | 6 | LYS A 226GLY A 227TYR A 271ASN A 298HIS A 299TYR A 336 | SAM A 401 (-4.6A)SAM A 401 ( 4.0A)SAM A 401 (-4.1A)SAM A 401 (-3.2A)NoneSAM A 401 (-4.8A) | 0.27A | 4ypaA-5tegA:14.3 | 4ypaA-5tegA:23.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1049TRP A1050ASN A1112HIS A1113CYH A1170 | SAM A1505 ( 3.9A)NoneSAM A1505 (-3.4A)SAM A1505 (-4.7A) ZN A1504 (-2.2A) | 1.18A | 4ypaA-5tuyA:18.6 | 4ypaA-5tuyA:28.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A1049TRP A1050TYR A1085ASN A1112HIS A1113TYR A1154CYH A1168 | SAM A1505 ( 3.9A)NoneSAM A1505 (-4.0A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A) ZN A1504 (-2.2A) | 0.36A | 4ypaA-5tuyA:18.6 | 4ypaA-5tuyA:28.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A1137TRP A1138TYR A1173ASN A1200HIS A1201TYR A1242CYH A1256 | SAM A3001 (-3.6A)NoneSAM A3001 (-4.0A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 ( 2.4A) | 0.47A | 4ypaA-5vsdA:18.7 | 4ypaA-5vsdA:29.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A1137TRP A1138TYR A1173HIS A1201TYR A1242CYH A1258 | SAM A3001 (-3.6A)NoneSAM A3001 (-4.0A)SAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 (-2.3A) | 1.33A | 4ypaA-5vsdA:18.7 | 4ypaA-5vsdA:29.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wg6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,POLYCOMBPROTEIN SUZ12(E.C.2.1.1.43)CHIMERA (Homo sapiens) |
no annotation | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | A9G A9009 ( 4.2A)NoneA9G A9009 (-3.1A)NoneNone | 0.63A | 4ypaA-5wg6A:19.6 | 4ypaA-5wg6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xxg | - (-) |
no annotation | 5 | GLY A 15ASN A 205HIS A 206TYR A 239CYH A 261 | SAM A 502 ( 3.9A)SAM A 502 (-3.1A)None8HR A 501 ( 4.0A) ZN A 503 (-2.2A) | 0.71A | 4ypaA-5xxgA:6.2 | 4ypaA-5xxgA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5y3r | DNA-DEPENDENTPROTEIN KINASECATALYTIC SUBUNIT (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF02259(FAT)PF02260(FATC)PF08163(NUC194) | 5 | GLY C3921ASP C3941HIS C3908CYH C3912ILE C3911 | None | 1.49A | 4ypaA-5y3rC:undetectable | 4ypaA-5y3rC:4.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yf0 | - (-) |
no annotation | 5 | GLY A 294TRP A 230TYR A 324ASN A 228ILE A 331 | NoneNoneNoneSAM A 505 (-3.7A)None | 1.49A | 4ypaA-5yf0A:undetectable | 4ypaA-5yf0A:20.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6c8s | LOGANIC ACIDO-METHYLTRANSFERASE (Catharanthusroseus) |
no annotation | 5 | LYS A 39GLY A 40ASN A 83TYR A 31GLN A 316 | NoneNoneSAH A 401 (-3.8A)SAH A 401 (-4.5A)None | 1.42A | 4ypaA-6c8sA:undetectable | 4ypaA-6c8sA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 7 | GLY A1156TRP A1157TYR A1200ASN A1223HIS A1224TYR A1261CYH A1273 | SAM A1301 (-3.6A)NoneSAM A1301 (-3.9A)SAM A1301 (-3.2A)NoneSAM A1301 (-4.9A) ZN A1304 ( 2.3A) | 0.24A | 4ypaA-6cenA:26.8 | 4ypaA-6cenA:41.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 6 | GLY A1156TRP A1157TYR A1200HIS A1224TYR A1261CYH A1275 | SAM A1301 (-3.6A)NoneSAM A1301 (-3.9A)NoneSAM A1301 (-4.9A) ZN A1304 (-2.3A) | 1.46A | 4ypaA-6cenA:26.8 | 4ypaA-6cenA:41.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 5 | GLY A1158TYR A1200HIS A1224TYR A1261CYH A1273 | NoneSAM A1301 (-3.9A)NoneSAM A1301 (-4.9A) ZN A1304 ( 2.3A) | 1.38A | 4ypaA-6cenA:26.8 | 4ypaA-6cenA:41.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 5 | GLY A1158TYR A1200HIS A1224TYR A1261CYH A1275 | NoneSAM A1301 (-3.9A)NoneSAM A1301 (-4.9A) ZN A1304 (-2.3A) | 1.06A | 4ypaA-6cenA:26.8 | 4ypaA-6cenA:41.03 |